Table 4.
Functions of m6A regulators in ncRNA metabolism.
ncRNA | Molecule | Cancer type | Biological function | Effect | Reference |
---|---|---|---|---|---|
miR221/222 | METTL3 | Bladder Cancer | Promote pri-miRNA processing | Positive | (126) |
miR-1246 | METTL3 | Colorectal Carcinoma | Promote pri-miRNA processing | Positive | (127) |
miR-143-3p | METTL3 | Non-Small Cell Lung Cancer | Promote pre-miRNA processing | Positive | (128) |
miR-29a | WTAP | Glioblastoma | Regulatory gene expression | Negative | (129) |
miR-34-5p/miR-181-5p | IGF2BP1 | Ovarian, Liver and Lung cancer | Maintain SRF target genes expression | Negative | (130) |
miR-491-5p | IGF2BP1 | Non-Small Cell Lung Cancer | Regulatory gene expression | Negative | (131) |
miR-29A-3P, miR-29B-3P, miR-222, miR-1266-5P, miR-1268a, and miR-671-3p | HNRNPA2B1 | Breast Carcinoma | Alter miRNAs transcriptome | Bidirectional | (132) |
Linc00958 and miR3619-5p | METTL3 | Hepatic Carcinoma | Stabilize lncRNA and enable the ceRNA model | Positive | (134) |
lncRNA-NEAT1 | ALKBH5 | Gastric Carcinoma | Promote interaction | Positive | (103) |
LINC01234 | HNRNPA2B1 | Non-Small Cell Lung Cancer | Promote interaction | Positive | (135) |
lncRNA-DANCR | IGF2BP2 | Pancreatic Carcinoma | Stabilize lncRNA | Positive | (136) |
XIST | WTAP/RBM15/RBM15B | Gene silencing on the X chromosome | Promote XIST -mediated gene repression | Positive | (29, 138) |
XIST | METTL14/YTHDF2 | Colorectal Carcinoma | Mediate XIST degradation | Positive | (139) |
circNSun2 | YTHDC1 | Colorectal Carcinoma | Promote cytoplasmic export of circRNAs | Positive | (140) |
circRNAs | YTHDF2 | Innate Immunity | Mediate circRNA degradation | Negative | (141) |